Key Points
• MR imaging is a powerful tool in the detection, diagnosis, staging, and follow-up of bone tumors.
• Images should be obtained with the smallest practical field of view in order to maximize image detail, while performing the entire study in a clinically practical time period.
• T1-weighted spin-echo images are particularly important in the evaluation of bone marrow, whereas intermediate-weighted images should be avoided.
• Fat suppression must be applied when obtaining T2-weighted fast spin-echo images to demarcate tumor from surrounding bone marrow and edema.
• Administration of a gadolinium-chelate contrast material can provide useful information in characterization of bone lesions, as well as in assessment of response to therapy and detection of recurrent tumor.
• Various MR imaging artifacts need to be recognized and appropriate steps taken to minimize their occurrence during image acquisition.
• The signal characteristics of a bone lesion, combined with its demonstrated morphology, location, and anatomic relationships, provide essential information that facilitates state-ofthe-art patient care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baere T de, Vanel D, Shapeero LG, Charpentier A, Terrier P, Paola M di (1992) Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging. Radiology 185:587−592
Baur A, Reiser MF (2000) Diffusion-weighted imaging of the musculoskeletal system in humans. Skeletal Radiol 29:555−562
Bitar R, Leung G, Perng R, Tadros S, Moody AR, Sarrazin J, McGregor C, Christakis M, Symons S, Nelson A, Roberts TP (2006) MR pulse sequences: what every radiologist wants to know but is afraid to ask. RadioGraphics 26:513−537
Bush CH (2000) The magnetic resonance imaging of musculoskeletal hemorrhage. Skeletal Radiol 29:1−9
Chang SD, Lee MJ, Munk PL, Janzen DL, MacKay A, Xiang QS (2001) MRI of spinal hardware: comparison of conventional T1-weighted sequence with a new metal artifact reduction sequence. Skeletal Radiol 30:213−218
Collidge TA, Thomson PC, Mark PB, Traynor JP, Jardine AG, Morris ST, Simpson K, Roditi GH (2007) Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology 245:168−175
Delfaut EM, Beltran J, Johnson G, Rousseau J, Marchandise X, Cotten A (1999) Fat suppression in MR imaging: techniques and pitfalls. RadioGraphics 19:373−382
Dick BW, Mitchell DG, Burk DL, Levy DW, Vinitski S, Rifkin M (1988) The effect of chemical shift misrepresentation on cortical bone thickness on MR imaging. Am J Roentgenol 151:537−538
Dyke JP, Panicek DM, Healey JH, Meyers PA, Huvos AG, Schwartz LH, Thaler HT, Tofts PS, Gorlick R, Koutcher JA, Ballon D (2003) Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging. Radiology 228:271−278
Eustace S, Goldberg R, Williamson D, Melhem ER, Oladipo O, Yucel EK, Jara H (1997) MR imaging of soft tissues adjacent to orthopaedic hardware: techniques to minimize susceptibility artefact. Clin Radiol 52:589−594
Fayad LM, Bluemke DA, McCarthy EF, Weber KL, Barker PB, Jacobs MA (2006) Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging 23:23−28
Fayad LM, Barker PB, Jacobs MA, Eng J, Weber KL, Kulesza P, Bluemke DA (2007) Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. Am J Roentgenol 188:1513−1520
Feydy A, Anract P, Tomeno B, Chevrot A, Drapé J-L (2006) Assessment of vascular invasion by musculoskeletal tumors of the limbs: use of contrast-enhanced MR angiography. Radiology 238:611−621
Gold GE, Han E, Stainsby J, Wright G, Brittain J, Beaulieu C (2004) Musculoskeletal MRI at 3.0 T: relaxation times and image contrast. Am J Roentgenol 183:343−351
Hayashida Y, Yakushiji T, Awai K, Katahira K, Nakayama Y, Shimomura O, Kitajima M, Hirai T, Yamashita Y, Mizuta H (2006) Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results. Eur Radiol 16:2637−2643
Hwang S, Panicek DM (2007a) Magnetic resonance imaging of bone marrow in oncology, part 1. Skeletal Radiol 36:913−920
Hwang S, Panicek DM (2007b) Magnetic resonance imaging of bone marrow in oncology, part 2. Skeletal Radiol 36:1017−1027
James SL, Hughes RJ, Ali KE, Saifuddin A (2006) MRI of bone marrow oedema associated with focal bone lesions. Clin Radiol 61:1003−1009
James SL, Panicek DM, Davies AM (2008) Bone marrow oedema associated with benign and malignant bone tumours. Eur J Radiol 67:11−21
Ladd ME (2007) High-field-strength magnetic resonance: potential and limits. Top Magn Reson Imaging 18:139−152
Mahnken AH, Nolte-Ernsting CC, Wildberger JE, Heussen N, Adam G, Wirtz DC, Piroth W, Bücker A, Biesterfeld S, Haage P, Günther RW (2003) Aneurysmal bone cyst: value of MR imaging and conventional radiography. Eur Radiol 13:1118−1124
Meyers PA, Gorlick R, Heller G, Casper E, Lane J, Huvos AG, Healey JH (1998) Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. J Clin Oncol 16:2452−2458
Mirowitz SA, Apicella P, Reinus WR, Hammerman AM (1994) MR imaging of bone marrow lesions: relative conspicuousness on T1-weighted, fat-suppressed T2-weighted, and STIR images. Am J Roentgenol 162:215−221
Petersilge CA, Lewin JS, Duerk JL, Yoo JU, Ghaneyem AJ (1996) Optimizing imaging parameters for MR evaluation of the spine with titanium pedicle screws. Am J Roentgenol 166:1213−1218
Sah PL, Sharma R, Kandpal H, Seith A, Rastogi S, Bandhu S, Jagannathan NR (2008) In vivo proton spectroscopy of giant cell tumor of the bone. Am J Roentgenol 190:W133−W139
Shabana WM, Cohan RH, Ellis JH, Hussain HK, Francis IR, Su LD, Mukherji SK, Swartz RD (2008) Nephrogenic systemic fibrosis: a report of 29 cases. Am J Roentgenol 190:736−741
Shuman WP, Patten RM, Baron RL, Liddell RM, Conrad EU, Richardson ML (1991) Comparison of STIR and spin-echo MR imaging at 1.5 T in 45 suspected extremity tumors: lesion conspicuity and extent. Radiology 179:247−252
Simpfendorfer CS, Ilaslan H, Davies AM, James SL, Obuchowski NA, Sundaram M (2008) Does the presence of focal normal marrow fat signal within a tumor on MRI exclude malignancy? An analysis of 184 histologically proven tumors of the pelvic and appendicular skeleton. Skeletal Radiol 37:797–804, 10.1007/s00256-008-0523-7
Suh JS, Jeong EK, Shin KH, Cho JH, JB Na, Kim DK, Han CD (1998) Minimizing artifacts caused by metallic implants at MR imaging: experimental and clinical studies. Am J Roentgenol 171:1207−1213
Van Dyck P, Vanhoenacker FM, Vogel J, Venstermans C, Kroon HM, Gielen J, Parizel PM, Bloem JL, De Schepper AM (2006) Prevalence, extension and characteristics of fluid-fluid levels in bone and soft tissue tumors. Eur Radiol 16:2644−2651
Vanel D, Bittoun J, Tardivon A (1998) MRI of bone metastases. Eur Radiol 8:1345−1351
Wang CK, Li CW, Hsieh TJ, Chien SH, Liu GC, Tsai KB (2004) Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results. Radiology 232:599−605
Zhuo J, Gullapalli RP (2006) MR artifacts, safety, and quality control. RadioGraphics 26:275−297
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hwang, S., Panicek, D. (2009). Imaging Techniques: Magnetic Resonance Imaging. In: Davies, A., Sundaram, M., James, S. (eds) Imaging of Bone Tumors and Tumor-Like Lesions. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-77984-1_3
Download citation
DOI: https://doi.org/10.1007/978-3-540-77984-1_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-77982-7
Online ISBN: 978-3-540-77984-1
eBook Packages: MedicineMedicine (R0)